Omeros reported $457.55M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acelrx Pharmaceuticals ACRX:US USD 48.31M 7.82M
Adma Biologics ADMA:US USD 300.56M 3.63M
Aerie Pharmaceuticals AERI:US USD 375.59M 9.75M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Cytokinetics CYTK:US USD 1.08B 304.24M
Dynavax Technologies DVAX:US USD 999.34M 23.66M
Gilead Sciences GILD:US USD 62.56B 313M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Insmed INSM:US USD 994.82M 58.54M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Knight Therapeutics Inc GUD:CN CAD 1.04B 34.21M
Macrogenics MGNX:US USD 195.35M 22.7M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Omeros OMER:US USD 457.55M 111.91M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Regulus Therapeutics RGLS:US USD 52.13M 2.17M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
United Therapeutics UTHR:US USD 5.78B 238.3M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
Vital Therapies VTL:US USD 121.08M 17.57M
Xoma XOMA:US USD 146.13M 8.09M